BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27758762)

  • 21. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Update of Neuroendocrine Tumors of the Female Reproductive System.
    Kefeli M; Usubütün A
    Turk Patoloji Derg; 2015; 31 Suppl 1():128-44. PubMed ID: 26177323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumours.
    Monaghan PJ; Lamarca A; Valle JW; Hubner RA; Mansoor W; Trainer PJ; Darby D
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):348-52. PubMed ID: 26608723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic neuroendocrine tumors: contemporary diagnosis and management.
    Parbhu SK; Adler DG
    Hosp Pract (1995); 2016 Aug; 44(3):109-19. PubMed ID: 27404266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical Testing in Neuroendocrine Tumors.
    Aluri V; Dillon JS
    Endocrinol Metab Clin North Am; 2017 Sep; 46(3):669-677. PubMed ID: 28760232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic neuroendocrine tumors.
    Krampitz GW; Norton JA
    Curr Probl Surg; 2013 Nov; 50(11):509-45. PubMed ID: 24206780
    [No Abstract]   [Full Text] [Related]  

  • 27. Pancreatic endocrine tumors.
    Oberg K
    Semin Oncol; 2010 Dec; 37(6):594-618. PubMed ID: 21167379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The diagnostic value of plasma chromogranin A in neuroendocrine tumors].
    Yang XO; Li JN; Qian JM; Yang H; Chen Q; Lu L
    Zhonghua Nei Ke Za Zhi; 2011 Feb; 50(2):124-7. PubMed ID: 21418832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Approaches to Neuroendocrine Neoplasms of Unknown Primary Site.
    Berner AM; Pipinikas C; Ryan A; Dibra H; Moghul I; Webster A; Luong TV; Thirlwell C
    Neuroendocrinology; 2020; 110(7-8):563-573. PubMed ID: 31658461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromogranin A in gastrinomas: Promises and pitfalls.
    Rehfeld JF
    Clin Chim Acta; 2015 Jun; 446():15-20. PubMed ID: 25861845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory tests for neuroendocrine tumours.
    Seregni E; Ferrari L; Stivanello M; Dogliotti L
    Q J Nucl Med; 2000 Mar; 44(1):22-41. PubMed ID: 10932599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment strategy for enteropancreatic neuroendocrine tumor].
    Doi R; Tsukada T
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():71-8. PubMed ID: 16457224
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms.
    Modlin IM; Bodei L; Kidd M
    Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):59-77. PubMed ID: 26971844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical Testing in Patients with Neuroendocrine Tumors.
    Granberg D
    Front Horm Res; 2015; 44():24-39. PubMed ID: 26303702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limitations of Chromogranin A in clinical practice.
    Marotta V; Nuzzo V; Ferrara T; Zuccoli A; Masone M; Nocerino L; Del Prete M; Marciello F; Ramundo V; Lombardi G; Vitale M; Colao A; Faggiano A
    Biomarkers; 2012 Mar; 17(2):186-91. PubMed ID: 22303881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical Management of Pancreatic Neuroendocrine Tumors.
    Chiruvella A; Kooby DA
    Surg Oncol Clin N Am; 2016 Apr; 25(2):401-21. PubMed ID: 27013372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chromogranin A: a marker of neuroendocrine tumors].
    D'Herbomez M; Gouze V
    Ann Biol Clin (Paris); 2002; 60(6):641-6. PubMed ID: 12446227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chromogranin A (CgA) - characteristic of the currently available laboratory methods and conditions which can influence the results].
    Glinicki P; Jeske W
    Endokrynol Pol; 2009; 60(5):415-9. PubMed ID: 19885814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors.
    Massironi S; Conte D; Sciola V; Spampatti MP; Ciafardini C; Valenti L; Rossi RE; Peracchi M
    Am J Gastroenterol; 2010 Sep; 105(9):2072-8. PubMed ID: 20372113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multimodal imaging of pancreatic neuroendocrine tumors].
    Müssig K; Bares R; Dudziak K; Horger M
    Rofo; 2008 May; 180(5):373-9. PubMed ID: 18464198
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.